Media

Oncopedtides – Update on the Type II application process

First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration

BONESUPPORT receives MDR certification for CERAMENT® BONE VOID FILLER and CERAMENT® V

Hemab Therapeutics Announces First Patient Dosed in Phase 2 Clinical Study Investigating HMB-001 for the Treatment of Glanzmann Thrombasthenia

Ariceum Therapeutics announces granting of US and Canadian patents for its Gallium-68 radiopharmaceutical production kit

Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte

Aro Biotherapeutics Secures $41.5M Series B Financing 

Priothera – US FDA grants Orphan Drug Designation to mocravimod to improve the outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with hematologic malignancies

Invitation to BONESUPPORT’s Capital Markets Day

Article with exploratory alkylator-refractory subgroup analysis from Oncopeptides’ OCEAN study observing longer PFS and OS in melflufen vs. pomalidomide published in European Journal of Haematology